Pharmaceutical composition and method for treating tumors suscep

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3133

Patent

active

046862153

ABSTRACT:
The pharmaceutical composition possessing antitumor activity against tumors susceptible to 2-carbamoylaziridine which consists of a therapeutically efficaceous quantity of 1-H-2-aziridinecarbonic acid derivative having the formula ##STR1## where R is NH.sub.2 and a pharmaceutically suitable solvent or filler. The pharmaceutical composition possesses a high activity against tumors susceptible to 2-carbamoylaziridine, a wide spectrum of antitumor effect and low toxicity (LD.sub.50 within the range of 3,000 and 3,500 mg/kg. The invention is also a method for treating malignant tumors susceptible to 2-carbamoxylaziridine by administration of 2-carbamoyl-aziridine.

REFERENCES:
Chemical Abstracts 59: 11424(b) (1967).
Chemical Abstracts 70: 10608(p) (1969).
Carter et al., Chemotherapy of Cancer, 2nd ed., a Wiley Medical Publication, N.Y., N.Y., 1981, pp. 26-43.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition and method for treating tumors suscep does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition and method for treating tumors suscep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition and method for treating tumors suscep will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-403000

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.